Ignite Creation Date:
2025-12-24 @ 3:14 PM
Ignite Modification Date:
2025-12-30 @ 1:14 AM
Study NCT ID:
NCT00136292
Status:
COMPLETED
Last Update Posted:
2020-03-11
First Post:
2005-08-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
Sponsor:
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2006-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-08-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-25
First Submit QC Date:
None
Study First Post Date:
2005-08-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-09
Last Update Post Date:
2020-03-11
Last Update Post Date Type:
ACTUAL